| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 64.008 | 245.872 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 64.008 | 245.874 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 61.279 | 197.492 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 2.729 | 48.382 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 2.338 | 41.625 |
| Employees | - | - | - | - | - | - | - | - | 0 | 2 |
Check the financial reports for the company - Otoclinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 18.187 | 21.553 |
| Current Assets | - | - | - | - | - | - | - | - | 23.251 | 64.247 |
| Inventories | - | - | - | - | - | - | - | - | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | - | 8.710 | 18.568 |
| Cash | - | - | - | - | - | - | - | - | 14.541 | 45.679 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 2.378 | 43.990 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 40.024 | 44.510 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Otoclinic S.r.l.